Skip to main content
. Author manuscript; available in PMC: 2013 Feb 28.
Published in final edited form as: Am J Cardiol. 2011 Jul 26;108(8):1136–1140. doi: 10.1016/j.amjcard.2011.06.017

Figure 3. Patient Predictors of Warfarin Treatment.

Figure 3

Patient characteristics were not strong predictors of warfarin treatment, including components of the CHADS2 score. The median rate ratio for site-level variation of 1.31 was larger than the estimates of effect for any of the patient factors, suggesting that practice level variation explained a larger proportion of the variance in warfarin treatment than individual patient factors.